Found: 10
Select item for more details and to access through your institution.
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40758-0
- By:
- Publication type:
- Article
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.642170
- By:
- Publication type:
- Article
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2759, doi. 10.1007/s00432-022-04039-5
- By:
- Publication type:
- Article
CD105 (Endoglin) as negative prognostic factor in AML.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54767-x
- By:
- Publication type:
- Article
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 2041, doi. 10.3390/diagnostics11112041
- By:
- Publication type:
- Article
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6122, doi. 10.3390/cancers13236122
- By:
- Publication type:
- Article
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2725, doi. 10.3390/cancers12102725
- By:
- Publication type:
- Article
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01995
- By:
- Publication type:
- Article
C‐Cbl regulates c‐MPL receptor trafficking and its internalization.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 21, p. 12491, doi. 10.1111/jcmm.15785
- By:
- Publication type:
- Article
Identification of CD105 (endoglin) as novel risk marker in CLL.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 4, p. 773, doi. 10.1007/s00277-022-04756-4
- By:
- Publication type:
- Article